Deployment
Hugo RAS at Dublin, Ireland
Medtronic (NYSE: MDT; founded 1949 in Minneapolis, with legal headquarters in Dublin) makes the Hugo robotic-assisted surgery system, the late-market big-medtech challenger to Intuitive's da Vinci. Hugo is a modular multi-port teleoperated platform that received its European CE mark for urologic and gynecologic procedures on October 11, 2021, and, in the key regulatory milestone, US FDA clearance on December 3, 2025 for urologic procedures only, including prostatectomy, nephrectomy, and cystectomy, backed by the Expand URO investigational-device-exemption trial of 137 patients that met its primary safety and efficacy endpoints and was presented at AUA 2025.
General-surgery and gynecologic US indications are planned submissions but are not yet cleared. The registry records Hugo at commercial maturity: it has been CE-marked and commercially used outside the US across more than 30 countries since 2021 and is now US-cleared for urology and entering US rollout.
Medtronic discloses no specific system installed-base count, citing only tens of thousands of procedures across 30-plus countries, so the unit count is left as an honest absence rather than invented. On AI substance, Hugo is a master-slave teleoperated system whose Touch Surgery digital and video ecosystem is analytics and recording rather than autonomy, with no verified shipped intraoperative AI guidance.
Hugo RAS by Medtronic · Catalog entry · 1 source · not yet field-verified · Surgical robots
Recent coverage
- Medtronic to unveil Touch Surgery Aide compute platform at SRS 2026Ben Smith, Deploy Editor · 2026-07-21
- Medtronic adds real-time AI to Hugo robotMedTech Dive · 2026-07-21
- Pacemaker manufacturer Medtronic warns patients cybercrooks may have swiped health dataThe Register · 2026-07-02
Medtronic Hugo RAS system deployed at hospitals in Europe and emerging markets for minimally invasive surgery.
Key facts
- Technology
- Hugo RAS system
- Coverage
- Hospitals in Europe and emerging markets
- Use Case
- Minimally invasive surgery
Exposure
- Customer segment
- healthcare
- Scale tier
- commercial 10 99
Each exposure value carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Safety record
7 incidents on record (2 serious, 3 moderate, 2 minor). Most recent: Jul 2026.
- serious
- 2
- moderate
- 3
- minor
- 2
- regulatory action
- 3
- malfunction
- 3
- injury
- 1
Most recent: Jul 2026
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Incidents on record (7)
- Medtronic Hugo surgical robot earns FDA clearance for additional indication2026-07-01 · Regulatory action
- Medtronic Hugo robotic surgery system cleared by FDA for urologic procedures2026-02-15 · Regulatory action
- FDA clears Medtronic Hugo robotic-assisted surgery system for urologic procedures2025-12-03 · Regulatory action
Direct incidents recorded against this deployment. Retracted incidents are excluded here but remain reachable at their canonical URLs.
- Trust tier
- Catalog entry · 1 source · not yet field-verifiedhow tiers work →
- Last updated
- 2026-08-21
- Model
- Hugo RAS
- Company
- Medtronic
- Location
- Dublin, Ireland
- Operator
- Medtronic
- Status
- operational
- Scale at site
- 11 to 100 units
- Site environment
- indoor
- Location precision
- verified coordinates
- First seen
- 2024-06-01
- ID
3c597886-fc25-48dd-b634-68db703c7f64
Timeline
- Jun 2024First recordedHugo RAS first documented operating at Dublin, Ireland.
- Aug 2026Current status: operational, reviewedLatest recorded state. New status transitions append here as the deployment-status recorder produces them.
On the deployment map
Hugo RAS operates in Dublin, Ireland. Explore the full verified map:
Sources (1)
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Hugo RAS at Dublin, Ireland.Common questions
What is the Hugo RAS deployment at Dublin, Ireland?
Who operates Hugo RAS at Dublin, Ireland?
When did the Hugo RAS deployment at Dublin, Ireland go live?
Have there been incidents at the Hugo RAS deployment at Dublin, Ireland?
Is Hugo RAS at Dublin, Ireland safe?
Deploy Watch
Track this deployment.
We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.
Machine-readable surfaces
- Markdown mirror: /deployments/medtronic-hugo-europe.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/robots/3c597886-fc25-48dd-b634-68db703c7f64
- Data documentation: /data
- Query this programmatically: Deploy MCP
Medtronic's product animation of its Hugo RAS system, showing the modular arm-carts and open console. The animation depicts the system, not an autonomous capability; the arms are surgeon-driven.
Medtronic's footage of a first patient procedure on its Hugo RAS robotic-assisted surgery system. The surgeon teleoperates from a master console; the system is never autonomous.
Medtronic's introduction of its Hugo RAS robotic-assisted surgery system. Hugo is teleoperated by a surgeon from a console; its US FDA clearance covers urologic procedures.